explore -WSS

explore

author：explore 2025-10-02 22:23:55 - browse：491

Garry Tan, CEO of Y Combinator Seb Daly/Web Summi

WASHINGTON — In San Francisco, Y Combinator’s firebrand chief executive Garry Tan is one of the startup economy’s most recognizable figures. Well before he became the leader of the coveted startup accelerator that bred global brands like Airbnb, Stripe and OpenAI, Tan was a self-made founder who sold his own company to Twitter.

But here in the nation’s political capital, Tan is far less known. He’s hoping to grow his influence here, offering up his vast network of founders as a source of expertise for regulators struggling to wrap their heads around new technologies like artificial intelligence and how best to rein it in.

“We’re happy to be a phone-a-friend for people who are trying to understand tech,” he told the Economic Club of Washington recently when asked how he’d measure success during Y Combinator’s first-ever policy-focused visit. “‘Little tech’ represents competition, and consumer choice,” he said later at a separate event in a dimly lit Senate room filled with a few dozen Congressional staffers.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Medicare to pay more for cardiac rehab in hospital outpatient clinics

WSS

Why the drug industry's warnings on the IRA's impact fall short

Midwives could help bridge maternal health disparities in the U.S.

FDA panel to weigh safety of artificial wombs for preterm births

Why the drug industry's warnings on the IRA's impact fall short

Eli Lilly CEO gives to Mike Pence presidential super PAC

White House Covid adviser calls on docs to combat misinformation

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Psychedelics group wrestles with new pharma identity

Information blocking fines are now fair game in health care

Medicare details structure of new drug price negotiation program

Senate bill would ban some hospital facility fees

Medical records are filled with copy

Popular nasal decongestant doesn't actually relieve congestion

The high cost of giving birth even with insurance

Free Covid tests will again be offered to all U.S. households

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Fed up with FDA, ALS advocates consider a take

entertainment

Generate Biomedicines machine learning biotech raises $273M

How medical schools plan to diversify without affirmative action

How to make the FDA’s new prescription one

Midwives could help bridge maternal health disparities in the U.S.

FDA proposes changes to key medical devices approval pathway

White House touts steps to stem shortages of cancer treatments

explore

Wikipedia

Wikipedia

entertainment